| Home |
| Site Map |
| News Archives |
| Environmental Health News |
| Illness Research |
| Articles |
| Treatment Information |
| Useful Lab Tests |
| Find A Doctor |
| Chemical Avoidance |
| Allergen Reduction |
| Water Filtration |
| Treatments & Products |
| Books |
| Dr. Teitelbaum's Column |
| Gloria Gilbčre's Column |
| Sick Building Syndrome |
| Seasonal Affective Disorder |
| Lyme Disease |
| Lupus |
| Hypoglycemia |
| Electrical Sensitivity |
| Adrenal Fatigue |
| Hypothyroidism |
| Sleep Apnea |
| Restless Leg Syndrome |
| Celiac Disease |
| Water Filters |
| SAD Light Boxes |
| Hepa Air Purifiers |
| HEPA Vacuum Cleaners |
| Nutritional Supplements |
| Home Test Kits |
| Cleaning Products |
| Personal Care |
| LifeWave Patches |
|
|
| Research - Candida & Gut Dysbiosis Research | |
|
J Infect Dis. 2007 Nov 1;196(9):1416-24. Epub 2007 Oct 2.
Human Lactoferrin-Derived Peptide's Antifungal Activities against Disseminated Candida albicans Infection.
Lupetti A, Brouwer CP, Bogaards SJ, Welling MM, de Heer E, Campa M, van Dissel JT, Friesen RH, Nibbering PH. Department of Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands. This e-mail address is being protected from spam bots, you need JavaScript enabled to view it .
Background. Because the human lactoferrin-derived peptide, hLF(1-11), exerts potent in vitro candidacidal activity, we investigated whether it displays antifungal activity against disseminated Candida albicans infections.
Methods. Neutropenic mice were intravenously infected with C. albicans and, 24 h later, were injected with hLF(1-11); 18 h later, the number of viable yeasts in the kidneys was determined microbiologically, the size and number of infectious foci were determined histologically, and serum cytokine levels were determined by immunoassays.
Results. hLF(1-11) was effective (maximum reduction, 1.5 logs) against disseminated C. albicans infections, and its antifungal activity leveled off at a concentration of 0.4 ng of hLF(1-11)/kg of body weight. The antifungal activity of hLF(1-11) was increased in mice injected with interleukin (IL)-10 neutralizing antibodies, which suggests that IL-10 reduces the antifungal activity of hLF(1-11). In agreement with this result was the finding that injection of high doses of hLF(1-11) into infected mice was accompanied by increased levels of IL-10 in serum. Microscopic analysis revealed that infectious foci in kidneys of hLF(1-11)-treated mice contained mainly blastoconidia, whereas filamentous forms were abundant in untreated mice. The peptide inhibited the in vitro morphological transition of C. albicans, in a dose-dependent manner
Conclusions. hLF(1-11) is effective against disseminated C. albicans infections; and its effects on C. albicans viability and virulence and on host cells may explain this antifungal activity.
PMID: 17922408 [PubMed - in process]
Comments (0)
![]() Write comment
Discuss this article on the forums. (0 posts) |
|
| < Prev | Next > |
|---|
| DISCOVERY CHANNEL SHOW WANTS TO HEAR YO... EI Show 10-06-08 21:58 |
| Posting for a friend: need immediate ho... kcgal 09-30-08 04:17 |
| Is anyone out there like me? aaronify 09-22-08 03:42 |
| Chemical Clothing. Ena 09-14-08 19:57 |
| SIBO/Candida teacupmama 09-14-08 19:05 |
Subscribe to our newsletter and receive regular updates of our latest content: